Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1967 2
1969 1
1971 1
1983 2
1984 1
1985 1
1986 4
1987 4
1988 3
1989 2
1990 5
1991 8
1992 6
1993 7
1994 8
1995 12
1996 16
1997 10
1998 13
1999 14
2000 25
2001 14
2002 14
2003 7
2004 12
2005 10
2006 14
2007 6
2008 11
2009 20
2010 19
2011 22
2012 17
2013 15
2014 14
2015 18
2016 16
2017 16
2018 16
2019 6
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11415906

383 results
Results by year
Filters applied: . Clear all
Page 1
Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.
Cha S, Pierce S, Knopp EA, Johnson G, Yang C, Ton A, Litt AW, Zagzag D. Cha S, et al. AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1109-16. AJNR Am J Neuroradiol. 2001. PMID: 11415906 Free article.
Proton MR spectroscopy of tumefactive demyelinating lesions.
Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Saindane AM, et al. AJNR Am J Neuroradiol. 2002 Sep;23(8):1378-86. AJNR Am J Neuroradiol. 2002. PMID: 12223381 Free article.
Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri.
Yang S, Wetzel S, Law M, Zagzag D, Cha S. Yang S, et al. AJNR Am J Neuroradiol. 2002 Mar;23(3):350-5. AJNR Am J Neuroradiol. 2002. PMID: 11900998 Free article.
Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS, Na DG, Kim KH, Kim JH, Kim E, Yun BL, Chang KH. Kim DS, et al. Radiology. 2009 May;251(2):467-75. doi: 10.1148/radiol.2512072071. Epub 2009 Mar 4. Radiology. 2009. PMID: 19261924
Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG. Lev MH, et al. AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21. AJNR Am J Neuroradiol. 2004. PMID: 14970020 Free article.
Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Calli C, et al. Eur J Radiol. 2006 Jun;58(3):394-403. doi: 10.1016/j.ejrad.2005.12.032. Epub 2006 Mar 9. Eur J Radiol. 2006. PMID: 16527438 Clinical Trial.
Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors.
Law M, Kazmi K, Wetzel S, Wang E, Iacob C, Zagzag D, Golfinos JG, Johnson G. Law M, et al. AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):997-1005. AJNR Am J Neuroradiol. 2004. PMID: 15205137 Free article.
Dynamic contrast-enhanced T2-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin.
Cha S, Knopp EA, Johnson G, Litt A, Glass J, Gruber ML, Lu S, Zagzag D. Cha S, et al. AJNR Am J Neuroradiol. 2000 May;21(5):881-90. AJNR Am J Neuroradiol. 2000. PMID: 10815664 Free article.
Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings.
Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M. Stadnik TW, et al. AJNR Am J Neuroradiol. 2001 May;22(5):969-76. AJNR Am J Neuroradiol. 2001. PMID: 11337344 Free article.
Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS, Jain KK, Agarwal A, Singh MK, Yadav SK, Husain M, Krishnani N, Gupta RK. Malhotra HS, et al. Mult Scler. 2009 Feb;15(2):193-203. doi: 10.1177/1352458508097922. Mult Scler. 2009. PMID: 19181773
383 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback